CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Director Matthew K Fust sold $119K of Crinetics Pharmaceuticals, Inc.
Sold$119,455
$20.96Price
5,700Shares
−31%Stake
What CRNX did after the filing
- The stock from Fri, Jul 15 close, $20.71
- −5.7%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Aug 26 close.
Traded Wed, Jul 13. Filed Fri, Jul 15, 12:30 PM ET, during the session. Returns use the Jul 15 close and the Aug 26 close. Not investment advice.